Chunyuan B. Xie

State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Arginine Polymer-Based Nanoplatform Facilitates Oral Co-Delivery of Antibody/Antigen for Robust Oral Immunotherapy in Orthotopic Colon Cancer.

Arginine Polymer-Based Nanoplatform Facilitates Oral Co-Delivery of Antibody/Antigen for Robust Oral Immunotherapy in Orthotopic Colon Cancer.

Journal: ACS nano

Published: May 27, 2026

An mRNA Tumor Nanovaccine Expressing Tumor Antigen Fused With Angiotensin II Facilitates Type 1 Conventional Dendritic Cell-Mediated Anti-Tumor Immunity.

An mRNA Tumor Nanovaccine Expressing Tumor Antigen Fused With Angiotensin II Facilitates Type 1 Conventional Dendritic Cell-Mediated Anti-Tumor Immunity.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: November 01, 2025

The microbial metabolite I3A inhibits ferroptosis and the effectiveness of redox-based cancer therapy.

The microbial metabolite I3A inhibits ferroptosis and the effectiveness of redox-based cancer therapy.

Journal: The Journal of biological chemistry

Published: August 14, 2025

RAC2 inhibition enhances tumor sensitivity to NK cell-mediated cytotoxicity.

RAC2 inhibition enhances tumor sensitivity to NK cell-mediated cytotoxicity.

Journal: Journal for immunotherapy of cancer

Published: April 14, 2025

A STING agonist potentiates C1 lipidoid-based mRNA cancer vaccine through promoting TNF-α secretion in vivo.

A STING agonist potentiates C1 lipidoid-based mRNA cancer vaccine through promoting TNF-α secretion in vivo.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: February 11, 2025

CBX2 suppresses interferon signaling to diminish tumor immunogenicity via a noncanonical corepressor complex.

CBX2 suppresses interferon signaling to diminish tumor immunogenicity via a noncanonical corepressor complex.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 30, 2025

Tryptophan Metabolite Indole-3-Aldehyde Induces AhR and c-MYC Degradation to Promote Tumor Immunogenicity.

Tryptophan Metabolite Indole-3-Aldehyde Induces AhR and c-MYC Degradation to Promote Tumor Immunogenicity.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 12, 2024

Pyrithione zinc alters mismatch repair to trigger tumor immunogenicity.

Pyrithione zinc alters mismatch repair to trigger tumor immunogenicity.

Journal: Oncogene

Published: July 24, 2024

Gastrodin Alleviates DSS-Induced Colitis in Mice through Strengthening Intestinal Barrier and Modulating Gut Microbiota.

Gastrodin Alleviates DSS-Induced Colitis in Mice through Strengthening Intestinal Barrier and Modulating Gut Microbiota.

Journal: Foods (Basel, Switzerland)

Published: May 07, 2024

Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity.

Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity.

Journal: The Journal of clinical investigation

Published: February 26, 2024

Cancer cell-intrinsic biosynthesis of itaconate promotes tumor immunogenicity.

Cancer cell-intrinsic biosynthesis of itaconate promotes tumor immunogenicity.

Journal: The EMBO journal

Published: January 30, 2024

Recent progress in mRNA cancer vaccines.

Recent progress in mRNA cancer vaccines.

Journal: Human vaccines & immunotherapeutics

Published: January 29, 2024

Showing 1-12 of 21

Last Updated: 09/26/2026